Correlation Between Dice Molecules and Vascular Biogenics

Can any of the company-specific risk be diversified away by investing in both Dice Molecules and Vascular Biogenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dice Molecules and Vascular Biogenics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dice Molecules Holdings and Vascular Biogenics, you can compare the effects of market volatilities on Dice Molecules and Vascular Biogenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dice Molecules with a short position of Vascular Biogenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dice Molecules and Vascular Biogenics.

Diversification Opportunities for Dice Molecules and Vascular Biogenics

-0.57

Correlation Coefficient

Dice Molecules  Vascular Biogenics

Excellent diversification

The 3 months correlation between Dice and Vascular is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Dice Molecules Holdings and Vascular Biogenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vascular Biogenics and Dice Molecules is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dice Molecules Holdings are associated (or correlated) with Vascular Biogenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vascular Biogenics has no effect on the direction of Dice Molecules i.e., Dice Molecules and Vascular Biogenics go up and down completely randomly.

Pair Corralation between Dice Molecules and Vascular Biogenics

Given the investment horizon of 90 days Dice Molecules Holdings is expected to generate 0.72 times more return on investment than Vascular Biogenics. However, Dice Molecules Holdings is 1.38 times less risky than Vascular Biogenics. It trades about 0.09 of its potential returns per unit of risk. Vascular Biogenics is currently generating about -0.04 per unit of risk. If you would invest  1,743  in Dice Molecules Holdings on January 25, 2024 and sell it today you would earn a total of  3,012  from holding Dice Molecules Holdings or generate 172.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	86.15%
Values	Daily Returns

Dice Molecules Holdings  vs.  Vascular Biogenics

Dice Molecules Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Vascular Biogenics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vascular Biogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Vascular Biogenics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Dice Molecules and Vascular Biogenics

The main advantage of trading using opposite Dice Molecules and Vascular Biogenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dice Molecules position performs unexpectedly, Vascular Biogenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vascular Biogenics will offset losses from the drop in Vascular Biogenics' long position.

The idea behind Dice Molecules Holdings and Vascular Biogenics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.